TNFRSF9 and neoplasm: As such, tumor-specific effector T cells were successfully isolated from peripheral blood based on the early expression of CD137 on most activated antigen-specific CD8+ T cells without prior knowledge of the specific immunogenic epitopes or HLA-restricted elements identified (74).